bortezomib,lenalidomide,dexamethasone,daratumumab
janssen,takeda
#ims2022 | douglas sborov presents the final analysis of the griffin trial of dara + rvd vs rvd, and adding daratumumab also in consolidation and maintenance therapy. ph iii data are awaited to definitely confirm the role of quadruplets in frontline tx #mmsm 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma